Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue
- PMID: 2453676
- DOI: 10.1093/jnci/80.9.691
Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue
Abstract
We characterized the subclass-specific keratins in the epithelium of normal, benign, and malignant breast tissue. Monoclonal antibody 34BE12 stained luminal as well as basal epithelium in normal and benign specimens and all tumor cells in malignant specimens. Antibody 312CS-1 reacted only with basal cells, and antibody LE61 reacted only with luminal cells in the normal and benign specimens. In 34 of 36 breast carcinomas examined, the basal and luminal cell-specific antibodies showed complementary patterns of reactivity, while in the remaining 2 specimens, neither antibody was reactive. The findings reported in this study demonstrate that expression of subclass-specific keratins is mutually exclusive not only in normal and benign mammary specimens but also in breast carcinoma. These findings suggest a role for epithelial subclass-specific antibodies in the histogenetic and prognostic subclassifications of breast carcinoma.
Similar articles
-
Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer.Int J Cancer. 1988 Aug 15;42(2):147-53. doi: 10.1002/ijc.2910420202. Int J Cancer. 1988. PMID: 2456993
-
Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours.Int J Cancer. 1985 Sep 15;36(3):299-306. Int J Cancer. 1985. PMID: 2411673
-
Paget cells express cytokeratins typical of glandular epithelia.Br J Dermatol. 1985 Feb;112(2):179-83. doi: 10.1111/j.1365-2133.1985.tb00081.x. Br J Dermatol. 1985. PMID: 2578801
-
Monoclonal antibody studies of mammalian epithelial keratins: a review.Ann N Y Acad Sci. 1985;455:307-29. doi: 10.1111/j.1749-6632.1985.tb50419.x. Ann N Y Acad Sci. 1985. PMID: 2417518 Review. No abstract available.
-
Keratins as biochemical markers of epithelial differentiation.Trends Genet. 1988 Oct;4(10):277-81. doi: 10.1016/0168-9525(88)90169-2. Trends Genet. 1988. PMID: 2474874 Review. No abstract available.
Cited by
-
Value of cytokeratin 5/6 immunostaining using D5/16 B4 antibody in the spectrum of proliferative intraepithelial lesions of the breast. A comparative study with 34betaE12 antibody.Virchows Arch. 2003 Jun;442(6):548-54. doi: 10.1007/s00428-003-0808-0. Epub 2003 Apr 24. Virchows Arch. 2003. PMID: 12712335
-
Update on triple-negative breast cancer: prognosis and management strategies.Int J Womens Health. 2012;4:511-20. doi: 10.2147/IJWH.S18541. Epub 2012 Sep 24. Int J Womens Health. 2012. PMID: 23071421 Free PMC article.
-
Transcription profiles of non-immortalized breast cancer cell lines.BMC Cancer. 2006 Apr 20;6:99. doi: 10.1186/1471-2407-6-99. BMC Cancer. 2006. PMID: 16626496 Free PMC article.
-
Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.Endocr Relat Cancer. 2000 Jun;7(2):95-113. doi: 10.1677/erc.0.0070095. Endocr Relat Cancer. 2000. PMID: 10903527 Free PMC article. Review.
-
Basal cell-specific and hyperproliferation-related keratins in human breast cancer.Am J Pathol. 1991 Mar;138(3):751-63. Am J Pathol. 1991. PMID: 1705754 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical